Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma

Published:2017-05-08 Issue:6 Volume:49 Page:825-833
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Feigin Michael E,Garvin Tyler,Bailey Peter,Waddell Nicola,Chang David K,Kelley David R,Shuai Shimin^ORCID,Gallinger Steven,McPherson John D,Grimmond Sean M,Khurana Ekta^ORCID,Stein Lincoln D,Biankin Andrew V^ORCID,Schatz Michael C,Tuveson David A

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.3861.pdf

Reference47 articles.

1. Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2013. CA Cancer J. Clin. 63, 11–30 (2013).

2. Jones, S. et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801–1806 (2008).

3. Biankin, A.V. et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491, 399–405 (2012).

4. Waddell, N. et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518, 495–501 (2015).

5. Huang, F.W. et al. Highly recurrent TERT promoter mutations in human melanoma. Science 339, 957–959 (2013).

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC;Gut;2024-04-26

2. Thyroid poorly differentiated carcinoma metastatic to pancreas diagnosed by fine‐needle aspiration and demonstrating a novel BRAF fusion;Cytopathology;2024-02-15

3. Identification of SLC12A8 as a Valuable Prognostic Biomarker and Immunotherapeutic Target by Comprehensive Pan-Cancer Analysis;Gene;2024-01

4. Non-coding mutations at enhancer clusters contribute to pancreatic ductal adenocarcinoma;2023-07-06

5. Non-coding mutations at enhancer clusters contribute to pancreatic ductal adenocarcinoma;2023-06-29